Your browser doesn't support javascript.
loading
The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma.
Boyle, Eileen M; Deshpande, Shayu; Tytarenko, Ruslana; Ashby, Cody; Wang, Yan; Bauer, Michael A; Johnson, Sarah K; Wardell, Christopher P; Thanendrarajan, Sharmilan; Zangari, Maurizio; Facon, Thierry; Dumontet, Charles; Barlogie, Bart; Arbini, Arnaldo; Rustad, Even H; Maura, Francesco; Landgren, Ola; Zhan, Fenghuang; van Rhee, Frits; Schinke, Carolina; Davies, Faith E; Morgan, Gareth J; Walker, Brian A.
Affiliation
  • Boyle EM; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Deshpande S; INSERM 1052/CNRS 5286 Cancer Research Center of Lyon, Lyon, France.
  • Tytarenko R; Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.
  • Ashby C; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Wang Y; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Bauer MA; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Johnson SK; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Wardell CP; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Thanendrarajan S; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Zangari M; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Facon T; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Dumontet C; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Barlogie B; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Arbini A; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Rustad EH; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Maura F; Service des maladies du sang. Hôpital Claude Huriez, Lille University Hospital, Lille, France.
  • Landgren O; INSERM 1052/CNRS 5286 Cancer Research Center of Lyon, Lyon, France.
  • Zhan F; Division of Hematology, The Mount Sinai Hospital, New York, NY, USA.
  • van Rhee F; Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.
  • Schinke C; Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.
  • Davies FE; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Morgan GJ; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Walker BA; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Nat Commun ; 12(1): 293, 2021 01 12.
Article in En | MEDLINE | ID: mdl-33436579
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Evolution, Molecular / Smoldering Multiple Myeloma Type of study: Diagnostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Nat Commun Year: 2021 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Evolution, Molecular / Smoldering Multiple Myeloma Type of study: Diagnostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Nat Commun Year: 2021 Document type: Article